Search

Start Over Rights http://creativecommons.org/publicdomain/mark/1.0/ Subject biochemie Harvested from CDK Harvested from CDK Data provider Academy of Sciences Library/Knihovna Akademie věd ČR

2. Cyklus Organická chemie

Creator:
Zdeněk Drahota and Ústav makromolekulární chemie (Československá akademie věd)
Publisher:
ČSAV. Ústav organické chemie a biochemie
Format:
print and v, 205 s.
Type:
model:monograph and TEXT
Subject:
Biochemie. Molekulární biologie. Biofyzika, biochemie, 577.1, (048.8), 2, and 577
Language:
Czech
Description:
Sv. 9, Vybrané kapitoly z biochemie, Z. Drahota ... [et al.]., and Na titulní str. uveden rok vydání 1982
Rights:
http://creativecommons.org/publicdomain/mark/1.0/ and policy:public

3. Látku GS-9219 nelze nazývat lékem

Creator:
Zdeněk Havlas and Antonín Holý
Format:
print, bez média, and svazek
Type:
article, prohlášení, model:article, and TEXT
Subject:
Věda. Všeobecnosti. Základy vědy a kultury. Vědecká práce, Ústav organické chemie a biochemie (Akademie věd ČR), biochemie, protinádorová terapie, léky, biochemistry, antineoplastic therapy, drugs, GS-9219, GS 9219, 12, and 00
Language:
Czech
Description:
Zdeněk Havlas, Antonín Holý.
Rights:
http://creativecommons.org/publicdomain/mark/1.0/ and policy:public

4. Nebezpečná konkurence nebo předčasně prozrazená naděje?

Creator:
Marina Hužvárová
Format:
print
Type:
article, rozhovory, model:article, and TEXT
Subject:
Věda. Všeobecnosti. Základy vědy a kultury. Vědecká práce, Holý, Antonín, 1936-2012, biochemie, antivirotika, konkurence, biochemistry, antiviral agents, competition, 12, and 00
Language:
Czech
Description:
Earlier this month, the Czech media reported that a highly efficient antiviral drug developed by Czech scientists has been shelved, reportedly for fear it would compete with existing medicines manufactured by pharmaceutical giants. The substance, known as MK-612, was designed at the Academy´s Institute of Organic Chemistry and Biochemistry. Academic Bulletin interviewed Zdeněk Havlas, headmaster of the Institute, about next stage in the future of this efficient substance MK-612. and Marina Hužvárová.
Rights:
http://creativecommons.org/publicdomain/mark/1.0/ and policy:public